Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02313181 · ClinicalTrials.gov registry record · NA
Early Limited Formula for Treating Lactation Concerns
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 328
- Enrollment target
NCT02313181 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 328 participants.
The verdict
NCT02313181, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 328 participants
- Enrollment target
Study Summary
This is a randomized, controlled trial designed to evaluate a new strategy for promoting continued breastfeeding for mothers and babies who initiated breastfeeding in the newborn period. The new strategy, called Early Limited Formula (ELF), consists of 10mL of formula fed to each baby by syringe after each breastfeeding prior to the onset of mature milk production. The study intervention is discontinued at the onset of mature milk production, and the investigators will then follow mothers and infants for 12 months to assess the effect of ELF on breastfeeding duration, maternal experience and healthcare utilization.
Interventions
- OTHER Standard Care
- OTHER Early Limited Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2015-01-07 |
| Est. Completion | 2017-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02313181
The ClinicalTrials.gov registry entry for NCT02313181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02313181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02313181 about?
NCT02313181 is a clinical study titled "Early Limited Formula for Treating Lactation Concerns". This is a randomized, controlled trial designed to evaluate a new strategy for promoting continued breastfeeding for mothers and babies who initiated breastfeeding in the newborn period. The new strategy, called Early Limited Formula (ELF), consists of 10mL of formula fed to each baby by syringe aft...
What is the current status of trial NCT02313181?
This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2015-01-07. Estimated completion is 2017-10-01.
What interventions are being tested in trial NCT02313181?
The interventions under investigation include: Standard Care (OTHER), Early Limited Formula (OTHER).
Who is sponsoring clinical trial NCT02313181?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.